Answers are grounded in this paper and cite their sources.
This Viewpoint reviews legalization initiatives for psychedelic substances and the concerns they raise by looking to the cautionary precedents involving the legalization and commercialization of other controlled substances.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: